San Diego County is responding to a rise in mpox infections with intensified public health outreach, after officials documented 16 new cases since October 2026 and confirmed ongoing local transmission involving distinct viral variants. This year’s total of 48 cases already surpasses the 35 recorded in all of 2025, signaling a concerning change in the county’s epidemiological landscape.
According to reporting by KESQ, the spread includes both the familiar Clade II variant—predominant statewide since the initial 2022 outbreak—and the less common but increasingly present Clade I, first documented in California in 2025. Local health authorities now believe several recent Clade I cases may have originated from within-state travel, though precise sources remain under active investigation.
Vaccine Uptake and Transmission Patterns
Of the 16 confirmed mpox cases since October, 10 occurred in individuals who had not received any vaccination. This trend, paired with evidence of local person-to-person spread, led county officials to intensify their vaccination campaign. The JYNNEOS vaccine, a two-dose regimen shown to be effective against both circulating variants, is available at county Sexual Health Clinics for those considered at risk or recently exposed.
County health officials shifted their surveillance approach, moving from monthly to weekly case reporting to better track infection patterns and facilitate timely outreach aimed at prevention. Officials are specifically urging people who are at higher risk—including men who have sex with men and those with known exposure—to talk to their healthcare providers about the mpox vaccine.
Mpox in San Diego: From Peak to New Concerns
Mpox, a viral illness with symptoms such as rash, fever, fatigue, and swollen lymph nodes, first appeared in the county in 2022 with 469 cases, a peak that triggered the establishment of public health protocols. In subsequent years, cases dropped well below 100 annually, but 2026’s rising numbers highlight persistent vulnerabilities, particularly among unvaccinated groups and with the appearance of new viral clades.
Transmission occurs primarily through close contact—most commonly during sexual contact—making targeted outreach and swift vaccination access central to the county’s current strategy. While no conflicting reports regarding the situation in San Diego County have surfaced, authorities caution that the possibility of unidentified clusters remains, especially given uncertainties surrounding Clade I’s spread.
Continuing Response and Public Guidance
As investigations continue, San Diego County health officials are underscoring the importance of prompt symptom recognition and reporting. Anyone experiencing mpox symptoms or who believes they may have been exposed should contact a healthcare provider and consider vaccination. Updated guidance and additional resources are now readily available on the county’s dedicated mpox information webpage.
Officials emphasize that the situation is ongoing and evolving. Expanded outreach, real-time data reporting, and community vaccination remain the backbone of San Diego’s public health response to curtail the further spread of mpox across the region.